| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/08/2006 | WO2006093080A1 PROCESS FOR PRODUCTION OF CHICKEN RECOMBINANT DIVALENT ANTIBODY FROM CHICKEN SINGLE-CHAIN VARIABLE FRAGMENT (scFv) AND ANTIBODY PRODUCED BY THE PROCESS |
| 09/08/2006 | WO2006093071A1 ANTI-IDIOTYPE ANTIBODY HAVING ANTIFUNGAL ACTIVITY ON FUNGUS CARRYING β-GLUCAN SYNTHASE AND UTILIZATION OF THE SAME |
| 09/08/2006 | WO2006093034A1 Mental disorder-related gene and use of the same |
| 09/08/2006 | WO2006092882A1 Novel altered gene from rice anthranilic acid synthase gene oasa2 and use thereof |
| 09/08/2006 | WO2006092738A2 Micrornas and related nucleic acids |
| 09/08/2006 | WO2006092714A2 Inhibition of spag9 expression with sirnas |
| 09/08/2006 | WO2006092631A2 Methyltransferases and their uses |
| 09/08/2006 | WO2006092582A1 Method for producing an amplified polynucleotide sequence |
| 09/08/2006 | WO2006092515A1 Transgenic mice and use thereof as an experimental model |
| 09/08/2006 | WO2006092449A2 Process for the production of fine chemicals |
| 09/08/2006 | WO2006092396A1 Aspergillus promotors for expressing a gene in a fungal cell |
| 09/08/2006 | WO2006092338A2 Tnf-alpha binding polypeptide , uses thereof and methods employing it |
| 09/08/2006 | WO2006092278A1 Use of nucleases for degrading nucleic acids in the presence of chaotropic agents and/or surfactants |
| 09/08/2006 | WO2006092175A1 Method for identifying pde11 modulators |
| 09/08/2006 | WO2006092174A1 Method for identifying pde10 modulators |
| 09/08/2006 | WO2006092099A1 Recombinant protein comprising starch binding domain and use thereof |
| 09/08/2006 | WO2006076099A3 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants |
| 09/08/2006 | WO2006067402A3 Agents inibiting the cathelin-like protein cap18/ll-37 |
| 09/08/2006 | WO2006058048A3 Method of determining a cellular response to a biological agent |
| 09/08/2006 | WO2006053021A3 Methods for engineering polypeptide variants via somatic hypermutation and polypeptides made thereby |
| 09/08/2006 | WO2006047323A3 Selectively permeable membranes on porous substrates |
| 09/08/2006 | WO2006046861A3 Tomato plants having higher levels of resistance to botrytis |
| 09/08/2006 | WO2006046076A3 Applications of isolated nucleic acid fragments comprising cpg islands |
| 09/08/2006 | WO2006042847A3 Method for the preparation of oxime, thiazolidine, dithiane, dithiolane or hydrazone linked analogues of growth hormone |
| 09/08/2006 | WO2006041488A8 Immortalized hepatocytes |
| 09/08/2006 | WO2006039652A3 Chondroitin sulfate a binding domains |
| 09/08/2006 | WO2006031901A3 SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF |
| 09/08/2006 | WO2005107690A3 Surface-active properties of surfactants |
| 09/08/2006 | WO2005103713A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 09/08/2006 | WO2005059515A3 Method for treating neurological disorders |
| 09/08/2006 | WO2005047479A3 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 09/08/2006 | WO2005044975A3 Genes encoding carotenoid compounds |
| 09/08/2006 | WO2005033290A3 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 09/08/2006 | WO2005025517A3 Animal model for protease activity and liver damage |
| 09/08/2006 | WO2004056963A3 B12 dependent dehydratases with improved reaction kinetics |
| 09/08/2006 | WO2004053106A3 Profiled regulatory sites useful for gene control |
| 09/08/2006 | WO2004028346A3 Detection methods |
| 09/08/2006 | WO2003062385A3 Secretory molecules |
| 09/08/2006 | CA2608859A1 New sources for, and types of, insecticidally active proteins, and polynucleotides that encode the proteins |
| 09/08/2006 | CA2604349A1 Method for identifying pde10 modulators |
| 09/08/2006 | CA2603677A1 Methyltransferases and their uses |
| 09/08/2006 | CA2600912A1 Transgenic mice and use thereof as an experimental model |
| 09/08/2006 | CA2600184A1 Compositions for use in identification of adventitious viruses |
| 09/08/2006 | CA2599866A1 Method of controlling the flavor of alcoholic drink |
| 09/08/2006 | CA2599734A1 Humanized l243 antibodies |
| 09/08/2006 | CA2599600A1 Formulations for therapeutic viruses having enhanced storage stability |
| 09/08/2006 | CA2599542A1 Signal amplification method |
| 09/08/2006 | CA2599265A1 Heterodimeric protein binding compositions |
| 09/08/2006 | CA2599180A1 Aspergillus promotors for expressing a gene in a fungal cell |
| 09/08/2006 | CA2598792A1 Process for the production of fine chemicals |
| 09/08/2006 | CA2598593A1 Method for identifying pde11 modulators |
| 09/08/2006 | CA2595529A1 Novel altered gene from rice anthranilic acid synthase gene oasa2 and use thereof |
| 09/08/2006 | CA2575611A1 Covalent tethering of functional groups to proteins and substrates therefor |
| 09/08/2006 | CA2573392A1 Methods of detecting a phenotype of a polymorphic protein |
| 09/07/2006 | WO2005074641B1 Variant neuronal nicotinic alpha-7 receptor and methods of use |
| 09/07/2006 | US20060200879 Heat and cold tolerance in plants; increasing abiotic stress tolerance in yeast comprising transforming yeast with a nucleic acid sequence encoding the protein |
| 09/07/2006 | US20060200878 Recombinant DNA constructs and methods for controlling gene expression |
| 09/07/2006 | US20060200877 Synthetic polynucleotides, which encode processing enzymes (alpha-amylase and glucoamylase) that are optimized for expression in plants; to produce fermentable substrates for the production of ethanol and fermented beverages |
| 09/07/2006 | US20060200876 Method for increasing stress-resistance to a plant |
| 09/07/2006 | US20060200875 Regulating the ethylene response of a plant by modulation of F-box proteins |
| 09/07/2006 | US20060200874 Novel glyphosate-N-acetyltransferase (GAT) genes |
| 09/07/2006 | US20060200873 Salicylic acid biosynthetic genes and uses thereof |
| 09/07/2006 | US20060200872 Tobacco products with reduced nicotine |
| 09/07/2006 | US20060200869 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| 09/07/2006 | US20060199953 Thionucleoside s-nitrosyl derivative |
| 09/07/2006 | US20060199947 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 09/07/2006 | US20060199779 Compositions and methods for short interfering nucleic acid inhibition of NAv1.8 |
| 09/07/2006 | US20060199778 Methods and products related to non-viral transfection |
| 09/07/2006 | US20060199777 Novel technology of intracellular delivery of dna oligonucleotides to improve drug activity |
| 09/07/2006 | US20060199266 CAEV-based vector systems |
| 09/07/2006 | US20060199249 Method for protein production |
| 09/07/2006 | US20060199247 Method for identifying modulators gene expression |
| 09/07/2006 | US20060199246 Zinc-regulated prokaryotic expression cassettes |
| 09/07/2006 | US20060199225 Modified chitin binding domain and uses thereof |
| 09/07/2006 | US20060199222 Bacillus transformation, transformants and mutant libraries |
| 09/07/2006 | US20060199218 Modulators of leukocyte activation, compositions and methods of use |
| 09/07/2006 | US20060199214 Incorporation of modified nucleotides by archaeon DNA polymerases and related methods |
| 09/07/2006 | US20060199212 freezing and thawing whole blood, then lysing leukocytes of the whole blood, and quantifying the specific mRNA in the lysate; lysate is transferred to an oligo(dT)-immobilized plate to capture the mRNA; use screening blood banks for HIV for example |
| 09/07/2006 | US20060199201 Targeted gene deletions for polysaccharide slime formers |
| 09/07/2006 | US20060199197 Isolation of rna, dna and proteins from formalin-fixed paraffin-embedded tissue specimens |
| 09/07/2006 | US20060199195 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 09/07/2006 | US20060199190 Detection and typing of bacterial strains |
| 09/07/2006 | US20060199185 Plasmid having a function of t-vector and expression vector, and expression of the target gene using the same |
| 09/07/2006 | US20060199184 Fusion protein is a partial fragment of developmentally regulated endothelial cell locus-1 (Del-1) protein; gene expression; drug delivery; side effect reduction |
| 09/07/2006 | US20060199182 Detecting by molecular identification a bacterium of one of the species of genus Streptococcus and four related genera Enterococcus, Gemella, Abiotrophia and Granulicatella which consists of using the rpoB gene or gene fragment as probe or primer |
| 09/07/2006 | US20060199179 Method for diagnosis of colorectal tumors |
| 09/07/2006 | US20060199176 Coronavirus S peptides |
| 09/07/2006 | US20060199168 Cell recovery |
| 09/07/2006 | US20060198853 Papilloma virus capsomere vaccine formulations and methods of use |
| 09/07/2006 | US20060198852 Collagen-binding MSCRAMMs of Bacillus anthracis and uses therefor |
| 09/07/2006 | US20060198845 Monoclonal antibody against human hepatoma and use thereof |
| 09/07/2006 | US20060198842 treating skeletal muscle atrophy with a corticotropin releasing factor 2 receptor (CRF2R) agonist such as Sauvagine, urocortin II or an antibody |
| 09/07/2006 | US20060198841 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 09/07/2006 | US20060198840 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 09/07/2006 | US20060198833 Compositions and methods for targeting a polypeptide to the central nervous system |
| 09/07/2006 | US20060198828 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a bcl-2 gene and the second hybridizing to a different type of oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers |
| 09/07/2006 | US20060198826 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 09/07/2006 | US20060198825 Reagents, methods and systems to suppress phospholamban expression |
| 09/07/2006 | US20060198792 SBD from glucoamylase of fungi genus Rhizopus for use as a tag; a recombinant protein containing this sequence can be more easily purified and separated by contacting with an affinity matrix such as starch, to which it will bind |
| 09/07/2006 | US20060198789 Target validation assay |